ArticleMathematical biosciences2022
A hybrid stochastic model and its Bayesian identification for infectious disease screening in a university campus with application to massive COVID-19 screening at the University of Liège.
Article in Mathematical biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A scoping review of COVID-19 modelling studies in Belgium 2020-2024: incorporation of behaviour and lessons learned.Archives of public health = Archives belges de sante publique · 2026Pooled it
- A comparative study of simulation-based inference methods for epidemic models with identifiability considerations.PLoS computational biology · 2026Article
- Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges.Nature communications · 2025Article
- Can infectious modelling be applicable globally - lessons from COVID 19.Current opinion in environmental science & health · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amid the COVID-19 pandemic, universities are implementing various prevention and mitigation measures. Identifying and isolating infectious individuals by using screening testing is one such a measure that can contribute to reducing spread. Here, we propose a hybrid stochastic model for infectious disease transmission in a university campus with screening testing and its surrounding community. Based on a compartmental modeling strategy, this hybrid stochastic model represents the evolution of the infectious disease and its transmission using continuous-time stochastic dynamics, and it represents the screening testing as discrete stochastic events. We also develop, in a Bayesian framework, the identification of parameters of this hybrid stochastic model, including transmission rates. These parameters were identified from the screening test data for the university population and observed incidence counts for the surrounding community. We implement the exploration of the Bayesian posterior using a machine-learning simulation-based inference approach. The proposed methodology was applied in a retrospective modeling study of a massive COVID-19 screening conducted at the University of Liège in Fall 2020. The emphasis of the paper is on the development of the hybrid stochastic model to assess the impact of screening testing as a measure to reduce spread. The hybrid stochastic model allows various factors to be represented and examined, such as interplay with the surrounding community, variability of the transmission dynamics, the rate of participation in the screening testing, the test sensitivity, the test frequency, the diagnosis delay, and compliance with isolation. The application in the retrospective modeling study suggests that a high rate of participation and a high test frequency are important factors to reduce spread.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.